

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.41619438 |
| 2 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.33643001 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 4.31618442 |
| 4 | startle response (GO:0001964) | 4.24797757 |
| 5 | serotonin receptor signaling pathway (GO:0007210) | 4.21852656 |
| 6 | vocalization behavior (GO:0071625) | 4.13330196 |
| 7 | auditory behavior (GO:0031223) | 4.02735242 |
| 8 | positive regulation of heat generation (GO:0031652) | 3.97465765 |
| 9 | regulation of fever generation (GO:0031620) | 3.93572670 |
| 10 | presynaptic membrane assembly (GO:0097105) | 3.80932360 |
| 11 | nucleobase catabolic process (GO:0046113) | 3.70131034 |
| 12 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.69421417 |
| 13 | defense response to protozoan (GO:0042832) | 3.69254503 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.66473641 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.63826111 |
| 16 | protein neddylation (GO:0045116) | 3.60251896 |
| 17 | mechanosensory behavior (GO:0007638) | 3.60006298 |
| 18 | opioid receptor signaling pathway (GO:0038003) | 3.45788427 |
| 19 | response to auditory stimulus (GO:0010996) | 3.45263361 |
| 20 | gamma-aminobutyric acid transport (GO:0015812) | 3.42633118 |
| 21 | negative regulation of mast cell activation (GO:0033004) | 3.39747874 |
| 22 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.37952291 |
| 23 | positive regulation of mast cell degranulation (GO:0043306) | 3.37952291 |
| 24 | positive regulation of mitochondrial fission (GO:0090141) | 3.35780439 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.34580858 |
| 26 | presynaptic membrane organization (GO:0097090) | 3.34447729 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34410351 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34410351 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.34410351 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34410351 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.34410351 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34410351 |
| 33 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.29476391 |
| 34 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.26361693 |
| 35 | response to peptidoglycan (GO:0032494) | 3.23480188 |
| 36 | axonal fasciculation (GO:0007413) | 3.19931337 |
| 37 | postsynaptic membrane organization (GO:0001941) | 3.17633994 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15759556 |
| 39 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12124606 |
| 40 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.09096385 |
| 41 | response to protozoan (GO:0001562) | 3.07507462 |
| 42 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.06585793 |
| 43 | protein localization to synapse (GO:0035418) | 3.05302613 |
| 44 | neutrophil mediated immunity (GO:0002446) | 3.03370618 |
| 45 | histamine secretion (GO:0001821) | 3.03114661 |
| 46 | regulation of action potential (GO:0098900) | 2.97923213 |
| 47 | behavioral response to nicotine (GO:0035095) | 2.96735379 |
| 48 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.96734929 |
| 49 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.95051350 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.95051350 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 2.95051350 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 2.93694551 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.91163463 |
| 54 | DNA double-strand break processing (GO:0000729) | 2.88215752 |
| 55 | cellular response to prostaglandin stimulus (GO:0071379) | 2.88049043 |
| 56 | protein complex biogenesis (GO:0070271) | 2.86949082 |
| 57 | positive regulation of action potential (GO:0045760) | 2.84925806 |
| 58 | establishment of mitochondrion localization (GO:0051654) | 2.83262345 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 2.81756960 |
| 60 | neuron recognition (GO:0008038) | 2.78529599 |
| 61 | negative chemotaxis (GO:0050919) | 2.78303114 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 2.78216329 |
| 63 | regulation of cilium movement (GO:0003352) | 2.76071496 |
| 64 | immunoglobulin mediated immune response (GO:0016064) | 2.75212510 |
| 65 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.75102846 |
| 66 | negative regulation of viral genome replication (GO:0045071) | 2.74786005 |
| 67 | synapse assembly (GO:0007416) | 2.74463895 |
| 68 | superoxide anion generation (GO:0042554) | 2.74422057 |
| 69 | regulation of heat generation (GO:0031650) | 2.71530329 |
| 70 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70763711 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 2.70228514 |
| 72 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.68990576 |
| 73 | regulation of mast cell activation (GO:0033003) | 2.68449599 |
| 74 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.68087183 |
| 75 | protein polyglutamylation (GO:0018095) | 2.67968900 |
| 76 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67430190 |
| 77 | positive regulation of amino acid transport (GO:0051957) | 2.66797176 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66468627 |
| 79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65789581 |
| 80 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.65115177 |
| 81 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.65073073 |
| 82 | coenzyme catabolic process (GO:0009109) | 2.64999083 |
| 83 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.64772263 |
| 84 | positive regulation of synapse assembly (GO:0051965) | 2.64496608 |
| 85 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.64237054 |
| 86 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.63696940 |
| 87 | establishment of melanosome localization (GO:0032401) | 2.61840643 |
| 88 | negative regulation of interleukin-17 production (GO:0032700) | 2.61669712 |
| 89 | methionine biosynthetic process (GO:0009086) | 2.61414666 |
| 90 | L-methionine salvage (GO:0071267) | 2.60933139 |
| 91 | L-methionine biosynthetic process (GO:0071265) | 2.60933139 |
| 92 | amino acid salvage (GO:0043102) | 2.60933139 |
| 93 | righting reflex (GO:0060013) | 2.60814234 |
| 94 | spinal cord association neuron differentiation (GO:0021527) | 2.59838130 |
| 95 | synaptic transmission, glutamatergic (GO:0035249) | 2.59009254 |
| 96 | neutrophil activation involved in immune response (GO:0002283) | 2.58443707 |
| 97 | hippocampus development (GO:0021766) | 2.58430885 |
| 98 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.58350798 |
| 99 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.58053444 |
| 100 | negative regulation of dendrite development (GO:2000171) | 2.57378597 |
| 101 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57369441 |
| 102 | response to pheromone (GO:0019236) | 2.56239455 |
| 103 | regulation of activation of Janus kinase activity (GO:0010533) | 2.56186104 |
| 104 | dopamine transport (GO:0015872) | 2.56115337 |
| 105 | endosome to pigment granule transport (GO:0043485) | 2.55961262 |
| 106 | endosome to melanosome transport (GO:0035646) | 2.55961262 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55530497 |
| 108 | response to host immune response (GO:0052572) | 2.55483095 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.55483095 |
| 110 | histamine transport (GO:0051608) | 2.55285270 |
| 111 | establishment of pigment granule localization (GO:0051905) | 2.54341490 |
| 112 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.53789996 |
| 113 | protein localization to cilium (GO:0061512) | 2.53695840 |
| 114 | phagosome maturation (GO:0090382) | 2.53176350 |
| 115 | alkaloid metabolic process (GO:0009820) | 2.53149516 |
| 116 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.52740177 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.52268894 |
| 118 | positive regulation of protein homodimerization activity (GO:0090073) | 2.51211972 |
| 119 | melanosome transport (GO:0032402) | 2.50786505 |
| 120 | intraciliary transport (GO:0042073) | 2.50741586 |
| 121 | heparin metabolic process (GO:0030202) | 2.50309433 |
| 122 | heparin biosynthetic process (GO:0030210) | 2.50309433 |
| 123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.50159959 |
| 124 | glycosphingolipid biosynthetic process (GO:0006688) | 2.49971724 |
| 125 | regulation of chemokine biosynthetic process (GO:0045073) | 2.49433372 |
| 126 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.48921310 |
| 127 | sympathetic nervous system development (GO:0048485) | 2.48854140 |
| 128 | negative regulation of heart rate (GO:0010459) | 2.48755540 |
| 129 | methionine metabolic process (GO:0006555) | 2.48625209 |
| 130 | regulation of synapse assembly (GO:0051963) | 2.47934319 |
| 131 | ubiquinone metabolic process (GO:0006743) | 2.47866705 |
| 132 | ubiquinone biosynthetic process (GO:0006744) | 2.47343028 |
| 133 | facial nerve structural organization (GO:0021612) | 2.45849080 |
| 134 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.45651595 |
| 135 | ribonucleoprotein complex disassembly (GO:0032988) | 2.45115340 |
| 136 | neurotransmitter biosynthetic process (GO:0042136) | 2.45029902 |
| 137 | oxidative demethylation (GO:0070989) | 2.43604376 |
| 138 | DNA integration (GO:0015074) | 2.43564156 |
| 139 | cellular ketone body metabolic process (GO:0046950) | 2.43542557 |
| 140 | pigment granule transport (GO:0051904) | 2.43448942 |
| 141 | protein-cofactor linkage (GO:0018065) | 2.43405038 |
| 142 | myeloid dendritic cell differentiation (GO:0043011) | 2.42981647 |
| 143 | T-helper 1 type immune response (GO:0042088) | 2.42977232 |
| 144 | central nervous system neuron axonogenesis (GO:0021955) | 2.42382260 |
| 145 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.41981273 |
| 146 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.40481795 |
| 147 | mature B cell differentiation (GO:0002335) | 2.40085494 |
| 148 | B cell homeostasis (GO:0001782) | 2.39902476 |
| 149 | myeloid leukocyte mediated immunity (GO:0002444) | 2.39712570 |
| 150 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.39221825 |
| 151 | ganglion development (GO:0061548) | 2.38156452 |
| 152 | regulation of immunoglobulin secretion (GO:0051023) | 2.37462571 |
| 153 | ketone body metabolic process (GO:1902224) | 2.37205974 |
| 154 | synaptic vesicle maturation (GO:0016188) | 2.37160955 |
| 155 | cullin deneddylation (GO:0010388) | 2.36916620 |
| 156 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.36028600 |
| 157 | organelle transport along microtubule (GO:0072384) | 2.35761047 |
| 158 | acrosome reaction (GO:0007340) | 2.35025359 |
| 159 | neuron-neuron synaptic transmission (GO:0007270) | 2.34638367 |
| 160 | myeloid dendritic cell activation (GO:0001773) | 2.34000789 |
| 161 | epithelial cilium movement (GO:0003351) | 2.32693698 |
| 162 | S-adenosylmethionine metabolic process (GO:0046500) | 2.31885592 |
| 163 | melanosome localization (GO:0032400) | 2.30411885 |
| 164 | de novo posttranslational protein folding (GO:0051084) | 2.29250017 |
| 165 | retinal cone cell development (GO:0046549) | 2.27814832 |
| 166 | vesicle localization (GO:0051648) | 2.27736439 |
| 167 | protein deneddylation (GO:0000338) | 2.25310221 |
| 168 | pigment granule localization (GO:0051875) | 2.24769815 |
| 169 | microtubule nucleation (GO:0007020) | 2.24587103 |
| 170 | dendrite morphogenesis (GO:0048813) | 2.23434528 |
| 171 | C4-dicarboxylate transport (GO:0015740) | 2.23387526 |
| 172 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.22250717 |
| 173 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.22179544 |
| 174 | platelet dense granule organization (GO:0060155) | 2.22069384 |
| 175 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.21983940 |
| 176 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.21983940 |
| 177 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.20146845 |
| 178 | de novo protein folding (GO:0006458) | 2.19976234 |
| 179 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.18287285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.54132522 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.18622568 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.80467262 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.26249956 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82183807 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.71756402 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.60362743 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.53612977 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36079284 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.32041016 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31509032 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.30272784 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29210436 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27575316 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19770064 |
| 16 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.18556349 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18282516 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16286069 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.14090808 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13611739 |
| 21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.10835481 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.08813025 |
| 23 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06127076 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04815419 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99648413 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.99346527 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.98687429 |
| 28 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.96859411 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95659664 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89580260 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89184890 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87721498 |
| 33 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86985945 |
| 34 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.85608789 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.83781246 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83265175 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77356328 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.69861041 |
| 39 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.68681223 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.67829827 |
| 41 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66748507 |
| 42 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64145208 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62637236 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.62520333 |
| 45 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.60018149 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55710341 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.54300505 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.54048574 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53801579 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.53289425 |
| 51 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52617989 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.52150547 |
| 53 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.52094406 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.49819652 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.49222992 |
| 56 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.49036444 |
| 57 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.49036444 |
| 58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47926050 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47810105 |
| 60 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47632528 |
| 61 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.46643917 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45881970 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44798956 |
| 64 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43664868 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43070535 |
| 66 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42683506 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41656289 |
| 68 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.40404514 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39549983 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38251547 |
| 71 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.37687711 |
| 72 | * CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.37388966 |
| 73 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.36786704 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.36606214 |
| 75 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.36489689 |
| 76 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.35943551 |
| 77 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35304766 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34412087 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33730955 |
| 80 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32643861 |
| 81 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32278109 |
| 82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30887070 |
| 83 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29229393 |
| 84 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.27569319 |
| 85 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24588884 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23970060 |
| 87 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22316763 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21056390 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20175194 |
| 90 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19433796 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18936264 |
| 92 | JUN_21703547_ChIP-Seq_K562_Human | 1.18846498 |
| 93 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18495631 |
| 94 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16165199 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14858143 |
| 96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12396308 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12328653 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11281559 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10803716 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10548486 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09642719 |
| 102 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09224030 |
| 103 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07797340 |
| 104 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.07617985 |
| 105 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07388361 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05788543 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05343764 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04810942 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04431801 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04431801 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04238407 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03581783 |
| 113 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.03248017 |
| 114 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03092179 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02566637 |
| 116 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02023083 |
| 117 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.02023083 |
| 118 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01350808 |
| 119 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.00271342 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99309895 |
| 121 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99208862 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98990986 |
| 123 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98739307 |
| 124 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.98474328 |
| 125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98172907 |
| 126 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.98010690 |
| 127 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.97786804 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97591577 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96146484 |
| 130 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96052291 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95646764 |
| 132 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95425707 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.95053642 |
| 134 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94906251 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.94724969 |
| 136 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94507852 |
| 137 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92144364 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92144364 |
| 139 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90814342 |
| 140 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.90487118 |
| 141 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90455574 |
| 142 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89140002 |
| 143 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86297164 |
| 144 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.85655564 |
| 145 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83800566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.23602839 |
| 2 | MP0006292_abnormal_olfactory_placode | 3.67989216 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.20989965 |
| 4 | MP0003880_abnormal_central_pattern | 2.97714600 |
| 5 | MP0004510_myositis | 2.75762847 |
| 6 | MP0002736_abnormal_nociception_after | 2.63549297 |
| 7 | MP0003787_abnormal_imprinting | 2.62064072 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.55463163 |
| 9 | MP0009785_altered_susceptibility_to | 2.49629875 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.48462261 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.41083628 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.39958412 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.39156311 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.35396172 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.23213927 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.20595018 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.19677271 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.18180820 |
| 19 | MP0003436_decreased_susceptibility_to | 2.14849093 |
| 20 | MP0009745_abnormal_behavioral_response | 2.08582122 |
| 21 | MP0002822_catalepsy | 2.06418969 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.03153776 |
| 23 | MP0005174_abnormal_tail_pigmentation | 1.90907096 |
| 24 | MP0003121_genomic_imprinting | 1.88831114 |
| 25 | MP0003303_peritoneal_inflammation | 1.83047727 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.81940991 |
| 27 | MP0005187_abnormal_penis_morphology | 1.76680750 |
| 28 | MP0002102_abnormal_ear_morphology | 1.72834189 |
| 29 | MP0000015_abnormal_ear_pigmentation | 1.69876298 |
| 30 | MP0005025_abnormal_response_to | 1.67482970 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.65503776 |
| 32 | MP0003724_increased_susceptibility_to | 1.65206359 |
| 33 | MP0002419_abnormal_innate_immunity | 1.64581008 |
| 34 | MP0001502_abnormal_circadian_rhythm | 1.61660922 |
| 35 | MP0002064_seizures | 1.60175567 |
| 36 | MP0003122_maternal_imprinting | 1.60164808 |
| 37 | MP0009697_abnormal_copulation | 1.59441505 |
| 38 | MP0000778_abnormal_nervous_system | 1.58624141 |
| 39 | MP0002938_white_spotting | 1.57593572 |
| 40 | MP0005171_absent_coat_pigmentation | 1.53660007 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.53183037 |
| 42 | MP0003195_calcinosis | 1.53074849 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.52634528 |
| 44 | MP0009764_decreased_sensitivity_to | 1.51445501 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.49671323 |
| 46 | MP0001529_abnormal_vocalization | 1.49421975 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.46372381 |
| 48 | MP0004145_abnormal_muscle_electrophysio | 1.45644071 |
| 49 | MP0000685_abnormal_immune_system | 1.45010362 |
| 50 | MP0004142_abnormal_muscle_tone | 1.44831150 |
| 51 | MP0005253_abnormal_eye_physiology | 1.44727444 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.43326356 |
| 53 | MP0002184_abnormal_innervation | 1.42254389 |
| 54 | MP0001984_abnormal_olfaction | 1.42244140 |
| 55 | MP0003646_muscle_fatigue | 1.42018593 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.39139834 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.38493202 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 1.37485264 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.34967431 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.33172174 |
| 61 | MP0008872_abnormal_physiological_respon | 1.33114736 |
| 62 | MP0005671_abnormal_response_to | 1.31342071 |
| 63 | MP0004130_abnormal_muscle_cell | 1.30789557 |
| 64 | MP0005397_hematopoietic_system_phenotyp | 1.30498968 |
| 65 | MP0001545_abnormal_hematopoietic_system | 1.30498968 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.29700436 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.29676310 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.28276008 |
| 69 | MP0003718_maternal_effect | 1.28039856 |
| 70 | MP0008995_early_reproductive_senescence | 1.27891371 |
| 71 | MP0009046_muscle_twitch | 1.27881002 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.26024130 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.25966120 |
| 74 | MP0002067_abnormal_sensory_capabilities | 1.24134881 |
| 75 | MP0002095_abnormal_skin_pigmentation | 1.23059497 |
| 76 | MP0000955_abnormal_spinal_cord | 1.20376236 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.19961979 |
| 78 | MP0002723_abnormal_immune_serum | 1.19889515 |
| 79 | MP0001188_hyperpigmentation | 1.19803614 |
| 80 | MP0001800_abnormal_humoral_immune | 1.19264581 |
| 81 | MP0006082_CNS_inflammation | 1.18820881 |
| 82 | MP0008775_abnormal_heart_ventricle | 1.18464323 |
| 83 | MP0004811_abnormal_neuron_physiology | 1.17044723 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.16845168 |
| 85 | MP0004808_abnormal_hematopoietic_stem | 1.16799096 |
| 86 | MP0002751_abnormal_autonomic_nervous | 1.16033560 |
| 87 | MP0003123_paternal_imprinting | 1.15319680 |
| 88 | MP0001970_abnormal_pain_threshold | 1.14927810 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.14127722 |
| 90 | MP0005386_behavior/neurological_phenoty | 1.13732739 |
| 91 | MP0004924_abnormal_behavior | 1.13732739 |
| 92 | MP0004085_abnormal_heartbeat | 1.13686903 |
| 93 | MP0002882_abnormal_neuron_morphology | 1.11902968 |
| 94 | MP0005084_abnormal_gallbladder_morpholo | 1.11893470 |
| 95 | MP0008058_abnormal_DNA_repair | 1.10509629 |
| 96 | MP0001819_abnormal_immune_cell | 1.10347505 |
| 97 | MP0002420_abnormal_adaptive_immunity | 1.08398803 |
| 98 | MP0003172_abnormal_lysosome_physiology | 1.05900303 |
| 99 | MP0002909_abnormal_adrenal_gland | 1.05412864 |
| 100 | MP0008789_abnormal_olfactory_epithelium | 1.04928580 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 1.02593766 |
| 102 | MP0005410_abnormal_fertilization | 0.97189734 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.96431951 |
| 104 | MP0002229_neurodegeneration | 0.95675092 |
| 105 | MP0005387_immune_system_phenotype | 0.95021509 |
| 106 | MP0001790_abnormal_immune_system | 0.95021509 |
| 107 | MP0002653_abnormal_ependyma_morphology | 0.95010775 |
| 108 | MP0000681_abnormal_thyroid_gland | 0.94198791 |
| 109 | MP0002398_abnormal_bone_marrow | 0.93760757 |
| 110 | MP0002160_abnormal_reproductive_system | 0.93291758 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 0.92993032 |
| 112 | MP0004270_analgesia | 0.90545080 |
| 113 | MP0003011_delayed_dark_adaptation | 0.89902777 |
| 114 | MP0001533_abnormal_skeleton_physiology | 0.89837719 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.89586859 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.89131960 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.88019912 |
| 118 | MP0005499_abnormal_olfactory_system | 0.88019912 |
| 119 | MP0003806_abnormal_nucleotide_metabolis | 0.87894500 |
| 120 | MP0004484_altered_response_of | 0.85837244 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.83259500 |
| 122 | MP0004036_abnormal_muscle_relaxation | 0.82118988 |
| 123 | MP0002139_abnormal_hepatobiliary_system | 0.81445546 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.80763620 |
| 125 | MP0005448_abnormal_energy_balance | 0.80597870 |
| 126 | MP0002069_abnormal_eating/drinking_beha | 0.80052948 |
| 127 | MP0000716_abnormal_immune_system | 0.79410673 |
| 128 | MP0005085_abnormal_gallbladder_physiolo | 0.79041000 |
| 129 | MP0002090_abnormal_vision | 0.78254104 |
| 130 | MP0001764_abnormal_homeostasis | 0.78142335 |
| 131 | MP0005408_hypopigmentation | 0.77764881 |
| 132 | MP0003698_abnormal_male_reproductive | 0.77544255 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.76899595 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.76446075 |
| 135 | MP0000647_abnormal_sebaceous_gland | 0.76414135 |
| 136 | MP0004742_abnormal_vestibular_system | 0.75424023 |
| 137 | MP0002272_abnormal_nervous_system | 0.74053330 |
| 138 | MP0003186_abnormal_redox_activity | 0.73624700 |
| 139 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73523836 |
| 140 | MP0002152_abnormal_brain_morphology | 0.72818575 |
| 141 | MP0009278_abnormal_bone_marrow | 0.72701658 |
| 142 | MP0000372_irregular_coat_pigmentation | 0.71426130 |
| 143 | MP0002006_tumorigenesis | 0.71277139 |
| 144 | MP0001905_abnormal_dopamine_level | 0.69751509 |
| 145 | MP0005257_abnormal_intraocular_pressure | 0.69440333 |
| 146 | MP0001486_abnormal_startle_reflex | 0.68017810 |
| 147 | MP0008961_abnormal_basal_metabolism | 0.67724202 |
| 148 | MP0000631_abnormal_neuroendocrine_gland | 0.66211529 |
| 149 | MP0004147_increased_porphyrin_level | 0.65544464 |
| 150 | MP0002734_abnormal_mechanical_nocicepti | 0.63888274 |
| 151 | MP0002429_abnormal_blood_cell | 0.63156025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Volvulus (HP:0002580) | 4.24714079 |
| 2 | Optic neuritis (HP:0100653) | 4.09410282 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.09410282 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.08337361 |
| 5 | Focal motor seizures (HP:0011153) | 4.02541254 |
| 6 | Protruding tongue (HP:0010808) | 4.02016642 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.99952001 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.96741593 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.88608491 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.70323632 |
| 11 | Tented upper lip vermilion (HP:0010804) | 3.66973936 |
| 12 | Febrile seizures (HP:0002373) | 3.64468149 |
| 13 | Abnormal hair whorl (HP:0010721) | 3.61353360 |
| 14 | Myositis (HP:0100614) | 3.46744257 |
| 15 | Orchitis (HP:0100796) | 3.42239292 |
| 16 | Hyperventilation (HP:0002883) | 3.36904702 |
| 17 | Cortical dysplasia (HP:0002539) | 3.32278850 |
| 18 | Limb dystonia (HP:0002451) | 3.29375972 |
| 19 | Acute necrotizing encephalopathy (HP:0006965) | 3.27502717 |
| 20 | Progressive inability to walk (HP:0002505) | 3.16708569 |
| 21 | Acute encephalopathy (HP:0006846) | 3.10647694 |
| 22 | Polyphagia (HP:0002591) | 3.07233065 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.04684401 |
| 24 | Pachygyria (HP:0001302) | 2.98074829 |
| 25 | Fair hair (HP:0002286) | 2.97893342 |
| 26 | Generalized aminoaciduria (HP:0002909) | 2.87061773 |
| 27 | Poor eye contact (HP:0000817) | 2.86783118 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.86502708 |
| 29 | Eczematoid dermatitis (HP:0000976) | 2.79984738 |
| 30 | Mitochondrial inheritance (HP:0001427) | 2.78155464 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 2.72995512 |
| 32 | Broad-based gait (HP:0002136) | 2.69960789 |
| 33 | Blue irides (HP:0000635) | 2.64417704 |
| 34 | Gingivitis (HP:0000230) | 2.64271054 |
| 35 | Increased CSF lactate (HP:0002490) | 2.63124619 |
| 36 | Abnormality of the labia minora (HP:0012880) | 2.61666673 |
| 37 | Drooling (HP:0002307) | 2.61146039 |
| 38 | Excessive salivation (HP:0003781) | 2.61146039 |
| 39 | Lipid accumulation in hepatocytes (HP:0006561) | 2.59894751 |
| 40 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.58353811 |
| 41 | Medial flaring of the eyebrow (HP:0010747) | 2.56336279 |
| 42 | Retinal dysplasia (HP:0007973) | 2.55914650 |
| 43 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.54197122 |
| 44 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.54197122 |
| 45 | Hepatic necrosis (HP:0002605) | 2.53839941 |
| 46 | Heterochromia iridis (HP:0001100) | 2.51271607 |
| 47 | Generalized hypopigmentation of hair (HP:0011358) | 2.50376679 |
| 48 | Stomatitis (HP:0010280) | 2.49990879 |
| 49 | Urinary urgency (HP:0000012) | 2.49779030 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.46724541 |
| 51 | Palpebral edema (HP:0100540) | 2.46441670 |
| 52 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.45640609 |
| 53 | Hypoplasia of the brainstem (HP:0002365) | 2.45640609 |
| 54 | Lissencephaly (HP:0001339) | 2.43852871 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.42514188 |
| 56 | Prolonged bleeding time (HP:0003010) | 2.39365311 |
| 57 | Absent speech (HP:0001344) | 2.37882684 |
| 58 | Cerebral edema (HP:0002181) | 2.33375334 |
| 59 | Abnormal social behavior (HP:0012433) | 2.32380312 |
| 60 | Impaired social interactions (HP:0000735) | 2.32380312 |
| 61 | Arterial thrombosis (HP:0004420) | 2.31130701 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.30839066 |
| 63 | Hyperglycinemia (HP:0002154) | 2.30835331 |
| 64 | Focal seizures (HP:0007359) | 2.30657381 |
| 65 | Epileptiform EEG discharges (HP:0011182) | 2.30335514 |
| 66 | Increased IgM level (HP:0003496) | 2.30046488 |
| 67 | Congenital primary aphakia (HP:0007707) | 2.28309301 |
| 68 | Failure to thrive in infancy (HP:0001531) | 2.27938164 |
| 69 | Inability to walk (HP:0002540) | 2.27900331 |
| 70 | Muscular hypotonia of the trunk (HP:0008936) | 2.22415329 |
| 71 | Prostate neoplasm (HP:0100787) | 2.22115862 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.21964485 |
| 73 | Chest pain (HP:0100749) | 2.21014845 |
| 74 | Pancreatic cysts (HP:0001737) | 2.20413443 |
| 75 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.18396808 |
| 76 | Hypothermia (HP:0002045) | 2.17499380 |
| 77 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.17044702 |
| 78 | Absent/shortened dynein arms (HP:0200106) | 2.17044702 |
| 79 | Asymmetry of the thorax (HP:0001555) | 2.15313058 |
| 80 | Inappropriate behavior (HP:0000719) | 2.14979303 |
| 81 | Exotropia (HP:0000577) | 2.13642912 |
| 82 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12864367 |
| 83 | Obstructive lung disease (HP:0006536) | 2.12864367 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11019832 |
| 85 | Tubulointerstitial nephritis (HP:0001970) | 2.09765635 |
| 86 | Hypsarrhythmia (HP:0002521) | 2.09733220 |
| 87 | Pancreatic fibrosis (HP:0100732) | 2.08876633 |
| 88 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08333680 |
| 89 | Vasculitis (HP:0002633) | 2.07776726 |
| 90 | Nephronophthisis (HP:0000090) | 2.07482984 |
| 91 | Large eyes (HP:0001090) | 2.06227353 |
| 92 | Esotropia (HP:0000565) | 2.05701162 |
| 93 | Type II lissencephaly (HP:0007260) | 2.04114789 |
| 94 | Widely spaced teeth (HP:0000687) | 2.04096208 |
| 95 | Poor suck (HP:0002033) | 2.03191887 |
| 96 | Gastrointestinal infarctions (HP:0005244) | 2.02343970 |
| 97 | Spastic tetraplegia (HP:0002510) | 2.01738171 |
| 98 | Keratoconjunctivitis (HP:0001096) | 2.00545906 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 2.00127969 |
| 100 | Glycosuria (HP:0003076) | 2.00127969 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98920608 |
| 102 | Polymicrogyria (HP:0002126) | 1.98318788 |
| 103 | Astrocytoma (HP:0009592) | 1.97652233 |
| 104 | Abnormality of the astrocytes (HP:0100707) | 1.97652233 |
| 105 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97426239 |
| 106 | Chronic hepatic failure (HP:0100626) | 1.95889125 |
| 107 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95390328 |
| 108 | Renal cortical cysts (HP:0000803) | 1.95180165 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94891306 |
| 110 | Abnormality of alanine metabolism (HP:0010916) | 1.94891306 |
| 111 | Hyperalaninemia (HP:0003348) | 1.94891306 |
| 112 | Progressive cerebellar ataxia (HP:0002073) | 1.94585003 |
| 113 | Gingival bleeding (HP:0000225) | 1.92274249 |
| 114 | Recurrent skin infections (HP:0001581) | 1.91579554 |
| 115 | Shoulder girdle muscle weakness (HP:0003547) | 1.91049053 |
| 116 | Abnormality of DNA repair (HP:0003254) | 1.90492189 |
| 117 | Open mouth (HP:0000194) | 1.89682035 |
| 118 | Abnormality of salivation (HP:0100755) | 1.89611150 |
| 119 | Lactic acidosis (HP:0003128) | 1.89367108 |
| 120 | Amblyopia (HP:0000646) | 1.89230823 |
| 121 | Atonic seizures (HP:0010819) | 1.88954039 |
| 122 | Rimmed vacuoles (HP:0003805) | 1.88833726 |
| 123 | Thyroid-stimulating hormone excess (HP:0002925) | 1.88519012 |
| 124 | Increased serum lactate (HP:0002151) | 1.88287642 |
| 125 | Myokymia (HP:0002411) | 1.87585207 |
| 126 | Decreased central vision (HP:0007663) | 1.87429271 |
| 127 | Genital tract atresia (HP:0001827) | 1.87039393 |
| 128 | Abnormality of the prostate (HP:0008775) | 1.86099663 |
| 129 | Abnormality of glycolysis (HP:0004366) | 1.85879941 |
| 130 | Alveolar cell carcinoma (HP:0006519) | 1.84419525 |
| 131 | Keratitis (HP:0000491) | 1.84103510 |
| 132 | White forelock (HP:0002211) | 1.83777462 |
| 133 | Neoplasm of head and neck (HP:0012288) | 1.83764004 |
| 134 | Esophageal neoplasm (HP:0100751) | 1.83764004 |
| 135 | Thrombocytosis (HP:0001894) | 1.83722651 |
| 136 | Cholecystitis (HP:0001082) | 1.83327718 |
| 137 | Abnormal gallbladder physiology (HP:0012438) | 1.83327718 |
| 138 | Hemoptysis (HP:0002105) | 1.82704336 |
| 139 | Hemiparesis (HP:0001269) | 1.82162501 |
| 140 | Sporadic (HP:0003745) | 1.81777271 |
| 141 | Abnormality of macrophages (HP:0004311) | 1.81586127 |
| 142 | Neurodegeneration (HP:0002180) | 1.80777679 |
| 143 | Acanthocytosis (HP:0001927) | 1.80562874 |
| 144 | Abnormality of the intervertebral disk (HP:0005108) | 1.80243621 |
| 145 | True hermaphroditism (HP:0010459) | 1.79950256 |
| 146 | Akinesia (HP:0002304) | 1.79759032 |
| 147 | Decreased muscle mass (HP:0003199) | 1.79758420 |
| 148 | Hip dysplasia (HP:0001385) | 1.79671880 |
| 149 | Gaze-evoked nystagmus (HP:0000640) | 1.79550335 |
| 150 | Optic disc pallor (HP:0000543) | 1.78830902 |
| 151 | Specific learning disability (HP:0001328) | 1.77730475 |
| 152 | Meningitis (HP:0001287) | 1.76830714 |
| 153 | Gait imbalance (HP:0002141) | 1.75967988 |
| 154 | Synophrys (HP:0000664) | 1.75776255 |
| 155 | Increased muscle lipid content (HP:0009058) | 1.75399345 |
| 156 | Papillary thyroid carcinoma (HP:0002895) | 1.74363146 |
| 157 | Cerebral hypomyelination (HP:0006808) | 1.74298601 |
| 158 | Optic nerve coloboma (HP:0000588) | 1.73575189 |
| 159 | Methylmalonic acidemia (HP:0002912) | 1.72879929 |
| 160 | Exertional dyspnea (HP:0002875) | 1.72183201 |
| 161 | Vaginal atresia (HP:0000148) | 1.71767898 |
| 162 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71084137 |
| 163 | Abnormality of the renal medulla (HP:0100957) | 1.69846455 |
| 164 | Bile duct proliferation (HP:0001408) | 1.69829752 |
| 165 | Abnormal biliary tract physiology (HP:0012439) | 1.69829752 |
| 166 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.69612511 |
| 167 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.69612511 |
| 168 | Sleep apnea (HP:0010535) | 1.69525905 |
| 169 | Cerebellar dysplasia (HP:0007033) | 1.68720736 |
| 170 | Abnormality of macular pigmentation (HP:0008002) | 1.68496693 |
| 171 | Periodontitis (HP:0000704) | 1.68366114 |
| 172 | Limb-girdle muscle atrophy (HP:0003797) | 1.67988569 |
| 173 | Acute lymphatic leukemia (HP:0006721) | 1.67833975 |
| 174 | Abnormal ciliary motility (HP:0012262) | 1.67823559 |
| 175 | Abnormality of the fingertips (HP:0001211) | 1.67694262 |
| 176 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66788990 |
| 177 | Hypophosphatemic rickets (HP:0004912) | 1.65786211 |
| 178 | Large for gestational age (HP:0001520) | 1.64895170 |
| 179 | Abnormality of lateral ventricle (HP:0030047) | 1.63894791 |
| 180 | Abolished electroretinogram (ERG) (HP:0000550) | 1.63872440 |
| 181 | Upper limb muscle weakness (HP:0003484) | 1.63638164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 5.52258128 |
| 2 | RIPK4 | 3.81283600 |
| 3 | CASK | 3.80106941 |
| 4 | MAP2K7 | 3.58443980 |
| 5 | MARK1 | 3.21801642 |
| 6 | NTRK2 | 3.16014224 |
| 7 | EIF2AK1 | 3.01503746 |
| 8 | WNK3 | 2.61617043 |
| 9 | MAP3K12 | 2.55232329 |
| 10 | MAP4K2 | 2.46089421 |
| 11 | PINK1 | 2.45843061 |
| 12 | SIK2 | 2.39810539 |
| 13 | TRIM28 | 2.39319876 |
| 14 | MAP3K4 | 2.32626111 |
| 15 | NTRK3 | 2.11891925 |
| 16 | CSNK1G3 | 2.11233277 |
| 17 | CSNK1A1L | 2.07206951 |
| 18 | MAP3K6 | 2.01913803 |
| 19 | FRK | 1.98052333 |
| 20 | TBK1 | 1.97816371 |
| 21 | PBK | 1.95338753 |
| 22 | CSNK1G2 | 1.92846527 |
| 23 | EIF2AK3 | 1.92089485 |
| 24 | TNIK | 1.88730405 |
| 25 | MAP3K14 | 1.85421781 |
| 26 | AKT3 | 1.84479826 |
| 27 | ACVR1B | 1.84467792 |
| 28 | IRAK4 | 1.77793098 |
| 29 | YES1 | 1.74929803 |
| 30 | EPHA3 | 1.68486504 |
| 31 | BMPR1B | 1.68405037 |
| 32 | BRD4 | 1.67113826 |
| 33 | BCKDK | 1.65821299 |
| 34 | PRKD3 | 1.63793414 |
| 35 | MAP2K4 | 1.60596469 |
| 36 | CSNK1G1 | 1.60324900 |
| 37 | MAPK13 | 1.54141626 |
| 38 | STK16 | 1.52181214 |
| 39 | ERBB3 | 1.50118262 |
| 40 | PAK3 | 1.47299179 |
| 41 | STK38L | 1.45207151 |
| 42 | MUSK | 1.44159750 |
| 43 | TXK | 1.39294812 |
| 44 | ADRBK2 | 1.35445964 |
| 45 | PLK2 | 1.33663683 |
| 46 | DAPK1 | 1.32411059 |
| 47 | JAK3 | 1.26180997 |
| 48 | DYRK2 | 1.26094646 |
| 49 | BLK | 1.25355646 |
| 50 | SRPK1 | 1.24040228 |
| 51 | DYRK3 | 1.23622036 |
| 52 | MINK1 | 1.23115855 |
| 53 | BMPR2 | 1.18779316 |
| 54 | KIT | 1.18660414 |
| 55 | EPHA4 | 1.16990600 |
| 56 | GRK1 | 1.13049145 |
| 57 | MAP3K5 | 1.10872376 |
| 58 | DAPK2 | 1.09666591 |
| 59 | MATK | 1.06571526 |
| 60 | CDK19 | 1.06007261 |
| 61 | FES | 1.04299416 |
| 62 | MST4 | 1.04148649 |
| 63 | PIM2 | 1.03117463 |
| 64 | CAMKK2 | 1.03049664 |
| 65 | SYK | 1.02676412 |
| 66 | MYLK | 0.99622875 |
| 67 | KSR1 | 0.99592739 |
| 68 | BCR | 0.98369166 |
| 69 | OBSCN | 0.93006417 |
| 70 | IKBKE | 0.90044667 |
| 71 | GRK7 | 0.87841264 |
| 72 | PRPF4B | 0.87155173 |
| 73 | IRAK2 | 0.85527702 |
| 74 | EIF2AK2 | 0.85507583 |
| 75 | NME1 | 0.84354021 |
| 76 | BTK | 0.84204951 |
| 77 | IKBKB | 0.84204360 |
| 78 | CSF1R | 0.84028126 |
| 79 | LIMK1 | 0.80620457 |
| 80 | VRK1 | 0.77982057 |
| 81 | SGK2 | 0.77397611 |
| 82 | CCNB1 | 0.75669023 |
| 83 | FER | 0.75459540 |
| 84 | TSSK6 | 0.74862169 |
| 85 | MAPKAPK5 | 0.70406587 |
| 86 | TAOK3 | 0.69078426 |
| 87 | RPS6KA5 | 0.68343200 |
| 88 | FGR | 0.64983685 |
| 89 | ADRBK1 | 0.64655146 |
| 90 | ZAP70 | 0.64551418 |
| 91 | PHKG2 | 0.64447951 |
| 92 | PHKG1 | 0.64447951 |
| 93 | CHUK | 0.64435944 |
| 94 | ERBB4 | 0.64190380 |
| 95 | LYN | 0.63663020 |
| 96 | RPS6KA2 | 0.63237322 |
| 97 | RPS6KB1 | 0.62821157 |
| 98 | PKN2 | 0.61848194 |
| 99 | JAK2 | 0.61712960 |
| 100 | MAPK4 | 0.60374568 |
| 101 | CDK5 | 0.60107345 |
| 102 | SIK1 | 0.57794479 |
| 103 | PDK2 | 0.54930159 |
| 104 | NEK1 | 0.54092592 |
| 105 | PKN1 | 0.52906945 |
| 106 | TGFBR1 | 0.52416228 |
| 107 | SGK223 | 0.52409768 |
| 108 | SGK494 | 0.52409768 |
| 109 | TESK1 | 0.49629482 |
| 110 | PLK3 | 0.48937035 |
| 111 | VRK2 | 0.47471354 |
| 112 | STK39 | 0.47235322 |
| 113 | CDK14 | 0.47060219 |
| 114 | PRKAA1 | 0.45918007 |
| 115 | CSNK1A1 | 0.44379689 |
| 116 | PRKCG | 0.43863333 |
| 117 | SGK3 | 0.43847362 |
| 118 | CAMK2A | 0.43846390 |
| 119 | HCK | 0.41715828 |
| 120 | INSRR | 0.41688751 |
| 121 | IRAK1 | 0.41118638 |
| 122 | STK24 | 0.39727086 |
| 123 | PRKCE | 0.39668306 |
| 124 | CDK3 | 0.38702098 |
| 125 | CAMK2G | 0.36656796 |
| 126 | WNK4 | 0.35649010 |
| 127 | CSNK1E | 0.35619421 |
| 128 | DYRK1A | 0.35456580 |
| 129 | PAK6 | 0.35323514 |
| 130 | TLK1 | 0.34910562 |
| 131 | NUAK1 | 0.33309326 |
| 132 | DAPK3 | 0.32825752 |
| 133 | CAMK2B | 0.32807406 |
| 134 | MKNK2 | 0.32191820 |
| 135 | PRKACA | 0.31863440 |
| 136 | PRKCD | 0.31614955 |
| 137 | PRKG1 | 0.31111052 |
| 138 | MARK3 | 0.29733852 |
| 139 | TEC | 0.29317017 |
| 140 | UHMK1 | 0.28901531 |
| 141 | FLT3 | 0.28209478 |
| 142 | SGK1 | 0.28156381 |
| 143 | ATR | 0.27879827 |
| 144 | FYN | 0.27076741 |
| 145 | CDK18 | 0.26132642 |
| 146 | AKT2 | 0.25575620 |
| 147 | DDR2 | 0.25557891 |
| 148 | RPS6KA6 | 0.23127770 |
| 149 | PRKCZ | 0.22331027 |
| 150 | RPS6KC1 | 0.21969277 |
| 151 | RPS6KL1 | 0.21969277 |
| 152 | ABL1 | 0.21835791 |
| 153 | ZAK | 0.21419144 |
| 154 | GRK5 | 0.21161216 |
| 155 | PTK2B | 0.20743607 |
| 156 | LCK | 0.19823751 |
| 157 | PIM1 | 0.19771119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.16607004 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.63683697 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.59736377 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43089563 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.40664183 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.38143315 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35368904 |
| 8 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.26120878 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24220316 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23735197 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17254962 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11555603 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.04872448 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03829363 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.01925358 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.92344169 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.86998343 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.81404705 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.77844482 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.72078757 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72065825 |
| 22 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.68487013 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.66827600 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.63836160 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.62298686 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.60316648 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59601222 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.59365643 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.59204913 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58842631 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58037857 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56480103 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.55480544 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.55411635 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.54645538 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53067861 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.52455736 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.51538468 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47668784 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47534410 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47201434 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.46167852 |
| 43 | Phototransduction_Homo sapiens_hsa04744 | 1.46025713 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45311583 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45284201 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.44928899 |
| 47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43773000 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.41964341 |
| 49 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.39861087 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 1.39128642 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38626507 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.38126712 |
| 53 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38084710 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 1.37771402 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36476575 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36380251 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35896982 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31415046 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30668924 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.26863121 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24037623 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23799408 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.23601317 |
| 64 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23350820 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22708017 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 1.19996152 |
| 67 | Malaria_Homo sapiens_hsa05144 | 1.18208314 |
| 68 | RNA polymerase_Homo sapiens_hsa03020 | 1.15613656 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14130904 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 1.13797757 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12716650 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10564676 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 1.10495537 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10161264 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10155781 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09873557 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08334978 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.07535567 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06422766 |
| 80 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04848235 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04156717 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04027566 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01209615 |
| 84 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01010367 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.00773098 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.99891636 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99513302 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98720186 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98458753 |
| 90 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98455054 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98125784 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97265638 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.96185391 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95938152 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.95868812 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93436380 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.93278258 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.92966877 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.92944826 |
| 100 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92324352 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91024079 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90725798 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90446549 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90280745 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90044002 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89710810 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.89558244 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88860171 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88780997 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88629106 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88562370 |
| 112 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87880425 |
| 113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87339044 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82557173 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81915441 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81099566 |
| 117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80286792 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79573708 |
| 119 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79573025 |
| 120 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78393025 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77768545 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.76394189 |
| 123 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75037226 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74524308 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74095799 |
| 126 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72700142 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72240551 |
| 128 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71209016 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70617412 |
| 130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67914458 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.66589463 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64842951 |
| 133 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.64445885 |
| 134 | Platelet activation_Homo sapiens_hsa04611 | 0.63849155 |
| 135 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62810005 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62063080 |
| 137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62025756 |
| 138 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.61785862 |
| 139 | Renin secretion_Homo sapiens_hsa04924 | 0.60838275 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.60120832 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59372979 |
| 142 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58507128 |
| 143 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56701748 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55100025 |
| 145 | Purine metabolism_Homo sapiens_hsa00230 | 0.53598823 |
| 146 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.52357210 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.50967908 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.50805435 |
| 149 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50096921 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | 0.49594329 |
| 151 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49117562 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48480935 |
| 153 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47519847 |
| 154 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47355836 |
| 155 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.46920809 |
| 156 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45889333 |
| 157 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45623895 |
| 158 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44653876 |
| 159 | RNA transport_Homo sapiens_hsa03013 | 0.43728278 |
| 160 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43604763 |
| 161 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43082195 |
| 162 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42708417 |
| 163 | Gap junction_Homo sapiens_hsa04540 | 0.42533153 |
| 164 | Salivary secretion_Homo sapiens_hsa04970 | 0.42362448 |
| 165 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40571835 |
| 166 | Glioma_Homo sapiens_hsa05214 | 0.38491131 |
| 167 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38114173 |
| 168 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37494641 |
| 169 | Insulin secretion_Homo sapiens_hsa04911 | 0.37179631 |
| 170 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37149239 |
| 171 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34301038 |
| 172 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34169765 |

